307 related articles for article (PubMed ID: 25314113)
1. Efficacy of a standardized isopropanolic black cohosh (Actaea racemosa) extract in treatment of uterine fibroids in comparison with tibolone among patients with menopausal symptoms.
Ross SM
Holist Nurs Pract; 2014; 28(6):386-91. PubMed ID: 25314113
[TBL] [Abstract][Full Text] [Related]
2. Menopause: a standardized isopropanolic black cohosh extract (remifemin) is found to be safe and effective for menopausal symptoms.
Ross SM
Holist Nurs Pract; 2012; 26(1):58-61. PubMed ID: 22157510
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms - comments on major statements of the Cochrane Collaboration report 2012 "black cohosh (Cimicifuga spp.) for menopausal symptoms (review)".
Beer AM; Osmers R; Schnitker J; Bai W; Mueck AO; Meden H
Gynecol Endocrinol; 2013 Dec; 29(12):1022-5. PubMed ID: 23992293
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].
Bai WP; Wang SY; Liu JL; Geng L; Hu LN; Zhang ZL; Chen SL; Zheng SR
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):597-600. PubMed ID: 20003788
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone.
Bai W; Henneicke-von Zepelin HH; Wang S; Zheng S; Liu J; Zhang Z; Geng L; Hu L; Jiao C; Liske E
Maturitas; 2007 Sep; 58(1):31-41. PubMed ID: 17587516
[TBL] [Abstract][Full Text] [Related]
6. Black cohosh: efficacy, safety, and use in clinical and preclinical applications.
McKenna DJ; Jones K; Humphrey S; Hughes K
Altern Ther Health Med; 2001; 7(3):93-100. PubMed ID: 11347288
[TBL] [Abstract][Full Text] [Related]
7. Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence.
Castelo-Branco C; Gambacciani M; Cano A; Minkin MJ; Rachoń D; Ruan X; Beer AM; Schnitker J; Henneicke-von Zepelin HH; Pickartz S
Climacteric; 2021 Apr; 24(2):109-119. PubMed ID: 33021111
[TBL] [Abstract][Full Text] [Related]
8. Effects of standardized isopropanolic black cohosh and estrogen on salivary function in ovariectomized rats.
Liu S; Niu K; Da Y; Liu Y; Zhang J; Wang W; Zhang Y; Jiang H; Wang K; Bai W; Qin L; Jia J
Biomed Pharmacother; 2018 Jan; 97():1438-1444. PubMed ID: 29156534
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.
Osmers R; Friede M; Liske E; Schnitker J; Freudenstein J; Henneicke-von Zepelin HH
Obstet Gynecol; 2005 May; 105(5 Pt 1):1074-83. PubMed ID: 15863547
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of Black cohosh (Actaea/Cimicifuga racemosa) in the treatment of vasomotor symptoms--review of clinical trials].
Kanadys WM; Leszczyńska-Gorzelak B; Oleszczuk J
Ginekol Pol; 2008 Apr; 79(4):287-96. PubMed ID: 18592868
[TBL] [Abstract][Full Text] [Related]
11. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy.
Borrelli F; Ernst E
Pharmacol Res; 2008 Jul; 58(1):8-14. PubMed ID: 18585461
[TBL] [Abstract][Full Text] [Related]
12. Black cohosh: an alternative therapy for menopause?
Mahady GB; Fabricant D; Chadwick LR; Dietz B
Nutr Clin Care; 2002; 5(6):283-9. PubMed ID: 12557811
[TBL] [Abstract][Full Text] [Related]
13. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study.
Rostock M; Fischer J; Mumm A; Stammwitz U; Saller R; Bartsch HH
Gynecol Endocrinol; 2011 Oct; 27(10):844-8. PubMed ID: 21231853
[TBL] [Abstract][Full Text] [Related]
14. Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract.
Naser B; Schnitker J; Minkin MJ; de Arriba SG; Nolte KU; Osmers R
Menopause; 2011 Apr; 18(4):366-75. PubMed ID: 21228727
[TBL] [Abstract][Full Text] [Related]
15. Black cohosh efficacy and safety for menopausal symptoms. The Spanish Menopause Society statement.
Castelo-Branco C; Navarro C; Beltrán E; Losa F; Camacho M;
Gynecol Endocrinol; 2022 May; 38(5):379-384. PubMed ID: 35403534
[TBL] [Abstract][Full Text] [Related]
16. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor.
Burdette JE; Liu J; Chen SN; Fabricant DS; Piersen CE; Barker EL; Pezzuto JM; Mesecar A; Van Breemen RB; Farnsworth NR; Bolton JL
J Agric Food Chem; 2003 Sep; 51(19):5661-70. PubMed ID: 12952416
[TBL] [Abstract][Full Text] [Related]
17. Black cohosh.
Kligler B
Am Fam Physician; 2003 Jul; 68(1):114-6. PubMed ID: 12887117
[TBL] [Abstract][Full Text] [Related]
18. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.
Frei-Kleiner S; Schaffner W; Rahlfs VW; Bodmer Ch; Birkhäuser M
Maturitas; 2005 Aug; 51(4):397-404. PubMed ID: 16039414
[TBL] [Abstract][Full Text] [Related]
19. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
[TBL] [Abstract][Full Text] [Related]
20. Black cohosh (Cimicifuga spp.) for menopausal symptoms.
Leach MJ; Moore V
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007244. PubMed ID: 22972105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]